TABLE OF CONTENTS
Volume 33, Issue 6 (June 1983)
Original Articles |
Erratum |
USAN Council |
Notes of the American Society for Clinical Pharmacology and Therapeutics |
Index to Volume 33
Commentary
New drug development during and after a period of regulatory change: Clinical research activity of major united states pharmacxeutical firms, 1958 to 1979
Maureen S May PhD, William M Wardell MD, PhD and Louis Lasagna MD Rochester, N.Y.
Clin Pharmacol Ther 33: 691-700; doi:10.1038/clpt.1983.95
Original Articles
Hemodynamics and leg muscle metabolism at rest and during exercise in young healthy men after prenalterol
Ulf Dahlström MD, Jan-Henrik Atterhög MD and Lennart Jorfeldt MD Linköping, Sweden
Clin Pharmacol Ther 33: 701-709; doi:10.1038/clpt.1983.96
Blood pressure and plasma norepinephrine concentrations after endogenous norepinephrine release by tyramine
A J I Scriven MB, C T Dollery MB, M B Murphy MB, I Macquin MD and M J Brown MB London, England
Clin Pharmacol Ther 33: 710-716; doi:10.1038/clpt.1983.97
Digitoxin kinetics and renal excretion in children
Anne Larsen MD and Liv Storstein MD Oslo, Norway
Clin Pharmacol Ther 33: 717-726; doi:10.1038/clpt.1983.98
Cardiac muscle mass during vasodilation therapy of hypertension
Jan I M Drayer MD, Julius M Gardin MD, Michael A Weber MD and Wilbert S Aronow MD Irvine and Long Beach, Calif., and Omaha, Neb.
Clin Pharmacol Ther 33: 727-732; doi:10.1038/clpt.1983.99
Constant kinetics and constant concentration-effect relationship during long-term 
3-blockade with pindolol
Renato L Galeazzi MD, Mauro Pirovino MD and Peter Weidmann MD Berne, Switzerland
Clin Pharmacol Ther 33: 733-740; doi:10.1038/clpt.1983.100
Antihypertensive and metabolic effects of a new converting enzyme inhibitor, enalapril
Steven G Chrysant MD, Ronald D Brown MD, David C Kern MD and Janet L Brown BS, RN Kansas City, Kan., and Oklahoma City, Okla.
Clin Pharmacol Ther 33: 741-746; doi:10.1038/clpt.1983.101
Isosorbide dinitrate kinetics and dynamics after intravenous, sublingual, and percutaneous dosing in angina
R A Morrison PhD, U.-W Wiegand PhD, E Jähnchen MD, D Höhmann MD, H Bechtold MD, T Meinertz MD and H.-L Fung PhD Buffalo, N.Y., and Mainz, Germany
Clin Pharmacol Ther 33: 747-756; doi:10.1038/clpt.1983.102
Mianserin kinetics in depressed patients
Pavel D Hrdina MD, PhD, Yvon D Lapierre MD, Brent Mclntosh and L K Oyewumi MD Ottawa, Ontario, Canada
Clin Pharmacol Ther 33: 757-762; doi:10.1038/clpt.1983.103
Tricyclic antidepressants and supine, standing, and exercise plasma norepinephrine levels
Richard C Veith MD, Murray A Raskind MD, Robert F Barnes MD, Gail Gumbrecht, James L Ritchie MD and Jeffrey B Halter MD Seattle, Wash.
Clin Pharmacol Ther 33: 763-769; doi:10.1038/clpt.1983.104
Caffeine metabolism and coffee-attributed sleep disturbances
Micha Levy MD and Ester Zylber-Katz PhD Jerusalem, Israel
Clin Pharmacol Ther 33: 770-775; doi:10.1038/clpt.1983.105
Platelet alpha-adrenergic receptors in obesity: Alteration with weight loss
Pavur R Sundaresan MD, PhD, Michael Weintraub MD, Linda A Hershey MD, PhD, Bruce H Kroening BS, Jeffrey D Hasday MD and Shailesh P Banerjee PhD Rochester, N.Y.
Clin Pharmacol Ther 33: 776-785; doi:10.1038/clpt.1983.106
Placental transfer and maternal midazolam kinetics
J Kanto MD, S Sjövall MD, R Erkkola MD, J-J Himberg MD, PhD and L Kangas MSc Helsinki and Turku, Finland
Clin Pharmacol Ther 33: 786-791; doi:10.1038/clpt.1983.107
Gallamine disposition in open-heart surgery involving cardiopulmonary bypass
Colin A Shanks MD, Iqbal M Ramzan PhD, Judy S M Walker Dip Pharm., (NZ) and Kenneth F Brown PhD Sydney, Australia
Clin Pharmacol Ther 33: 792-799; doi:10.1038/clpt.1983.108
Effects of cigarette smoking and oral nicotine on hand tremor
Saul M Shiffman PhD, Ellen R Gritz PhD, Joan Maltese PhD, Monroe A Lee, Nina G Schneider PhD and Murray E Jarvik MD, PhD Los Angeles, Calif., and Tampa, Fla.
Clin Pharmacol Ther 33: 800-805; doi:10.1038/clpt.1983.109
Cigarette smoking and subjective response in alcoholics: Effects of pentobarbital
Jack E Henningfield PhD, Larry D Chait PhD and Roland R Griffiths PhD Baltimore, Md.
Clin Pharmacol Ther 33: 806-812; doi:10.1038/clpt.1983.110
Diflunisal disposition and hypouricemic response in osteoarthritis
Peter J Meffin PhD, P M Brooks MD, J Bertouch MBBS, J R Veenendaal MApplSci and B J Harrington Dip Appl Sci Bedford Park, Australia
Clin Pharmacol Ther 33: 813-821; doi:10.1038/clpt.1983.111
Effect of probenecid on dyphylline elimination
David C May MD, PhD and Charles H Jarboe PhD Louisville, Ky.
Clin Pharmacol Ther 33: 822-825; doi:10.1038/clpt.1983.112
Treatment of noninsulin-dependent diabetes mellitus with enzyme inducers
Eero A Sotaniemi MD, Arno J Arranto MD, Seppo Sutinen MD, Jari H Stengård MD and Sirkka Sutinen MA Oulu, Finland
Clin Pharmacol Ther 33: 826-835; doi:10.1038/clpt.1983.113
Erratum
Top of pageUSAN Council
Top of pageNotes of the American Society for Clinical Pharmacology and Therapeutics
Notes of the American Society for Clinical Pharmacology and Therapeutics
Clin Pharmacol Ther 33: 838; doi:10.1038/clpt.1983.116
